Zydus Pharmaceuticals Ltd. - (Amalgamated) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Zydus Pharmaceuticals Ltd. - (Amalgamated) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Zydus Pharmaceutical

Based on:

M-Cap below 100cr DeciZen not available

Zydus Pharmaceuticals Ltd. - (Amalgamated) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Zydus Pharmaceutical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12TTM
ROCE % 10%6.7%20%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000
Sales YoY Gr.-NANA-
Adj EPS 1.20.81.30
YoY Gr.--31%58.8%-
BVPS (₹) 17.417.600
Adj Net
Profit
0.10.10.10
Cash Flow from Ops. 1.1-0.10-
Debt/CF from Ops. 000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANA58.8%
BVPSNANANA-100%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12TTM
Return on
Equity %
6.74.614.5NAN
Op. Profit
Mgn %
000NAN
Net Profit
Mgn %
000NAN
Debt to
Equity
000-
Working Cap
Days
0000
Cash Conv.
Cycle
0000

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Zydus Pharmaceuticals Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) - -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Zydus Pharmaceutical:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Zydus Pharmaceutical - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Zydus Pharmaceutical

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12
Sales000
Operating Expenses 0.030.010
Manufacturing Costs000
Material Costs000
Employee Cost 000
Other Costs 0.030.010
Operating Profit -0.03-0.01-0
Operating Profit Margin (%) ---
Other Income 0.190.120.17
Interest 000
Depreciation 000
Exceptional Items 000
Profit Before Tax 0.160.110.17
Tax 0.060.030.05
Profit After Tax 0.110.080.12
PAT Margin (%) ---
Adjusted EPS (₹)1.10.80.0
Dividend Payout Ratio (%)447%63%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12

Equity and Liabilities

Shareholders Fund 1.651.671.73
Share Capital 0.950.950.95
Reserves 0.700.720.78
Minority Interest000
Debt000
Long Term Debt000
Short Term Debt000
Trade Payables0.060.060
Others Liabilities 0.700.20-1.73
Total Liabilities 2.411.930

Fixed Assets

Gross Block0.080.080.06
Accumulated Depreciation0.020.020
Net Fixed Assets 0.060.060.06
CWIP 000
Investments 0.090.090
Inventories000
Trade Receivables000.05
Cash Equivalents flag 2.141.651.78
Others Assets 0.110.12-1.89
Total Assets 2.411.930

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11
Cash Flow From Operating Activity 1.13-0.05
PBT 0.160.11
Adjustment -0.19-0.12
Changes in Working Capital 1.21-0.01
Tax Paid -0.06-0.03
Cash Flow From Investing Activity 0.180.11
Capex 00
Net Investments 00
Others 0.180.11
Cash Flow From Financing Activity 0-0.55
Net Proceeds from Shares 00
Net Proceeds from Borrowing 00
Interest Paid 00
Dividend Paid 0-0.48
Others 0-0.08
Net Cash Flow 1.31-0.49

Finance Ratio

PARTICULARSMar'10Mar'11Mar'12
Ratios
ROE (%)6.454.587.1
ROCE (%)9.986.6719.97
Asset Turnover Ratio000
PAT to CFO Conversion(x)10.27-0.630
Working Capital Days
Receivable Days000
Inventory Days000
Payable Days000

Zydus Pharmaceuticals Ltd. - (Amalgamated) Stock News

Zydus Pharmaceuticals Ltd. - (Amalgamated) FAQs

The current trading price of Zydus Pharmaceutical on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zydus Pharmaceutical stood at ₹0.00.
The latest P/E ratio of Zydus Pharmaceutical as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Zydus Pharmaceutical as of 31-Dec-1969 is 0.00.
The 52-week high of Zydus Pharmaceutical is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Pharmaceutical is ₹0.00 ( Cr.) .

About Zydus Pharmaceuticals Ltd. - (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×